Female-led stocks: Who rules the world?
35 No. of Symbols
Next report date
Report period
Q1 2024
EPS estimate
0.43EUR
Revenue estimate
8.29 BEUR
1.405EUR
5.68 BEUR
34.98 BEUR
3.73 B
About GSK PLC LS-,3125
Sector
CEO
Emma N. Walmsley
Headquarters
Middlesex
Website
Employees (FY)
70.21 K
ISIN
GB00BN7SWP63
FIGI
BBG000CTGY55
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where GS71 is featured.
Frequently Asked Questions
The current price of GS71 is 19.000 EUR — it has increased by 1.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange GSK PLC LS-,3125 stocks are traded under the ticker GS71.
GSK PLC LS-,3125 is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
GS71 stock is 1.58% volatile and has beta coefficient of 0.48. Check out the list of the most volatile stocks — is GSK PLC LS-,3125 there?
GS71 earnings for the last quarter are 0.58 EUR per share, whereas the estimation was 0.53 EUR resulting in a 10.63% surprise. The estimated earnings for the next quarter are 0.33 EUR per share. See more details about GSK PLC LS-,3125 earnings.
GSK PLC LS-,3125 revenue for the last quarter amounts to 9.40 B EUR despite the estimated figure of 8.89 B EUR. In the next quarter revenue is expected to reach 8.79 B EUR.
Yes, you can track GSK PLC LS-,3125 financials in yearly and quarterly reports right on TradingView.
GS71 stock has risen by 2.04% compared to the previous week, the month change is a 4.51% fall, over the last year GSK PLC LS-,3125 has showed a 12.31% increase.
GS71 net income for the last quarter is 403.67 M EUR, while the quarter before that showed 1.69 B EUR of net income which accounts for −76.10% change. Track more GSK PLC LS-,3125 financial stats to get the full picture.
Today GSK PLC LS-,3125 has the market capitalization of 77.31 B, it has increased by 0.86% over the last week.
GSK PLC LS-,3125 dividend yield was 4.00% in 2023, and payout ratio reached 47.69%. The year before the numbers were 4.26% and 16.49% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, GS71 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GSK PLC LS-,3125 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 70.21 K employees. See our rating of the largest employees — is GSK PLC LS-,3125 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GSK PLC LS-,3125 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GSK PLC LS-,3125 stock shows the buy signal. See more of GSK PLC LS-,3125 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GSK PLC LS-,3125 future price: according to them, GS71 price has a max estimate of 29.57 EUR and a min estimate of 13.92 EUR. Read a more detailed GSK PLC LS-,3125 forecast: see what analysts think of GSK PLC LS-,3125 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GSK PLC LS-,3125 EBITDA is 11.31 B EUR, and current EBITDA margin is 30.62%. See more stats in GSK PLC LS-,3125 financial statements.